✦ LIBER ✦

Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome

✍ Scribed by Jose M. Ruiz-Moreno; Javier A. Montero

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for visual outcomes 2

✍ Nakanishi, H; Tsujikawa, A; Yodoi, Y; Ojima, Y; Otani, A; Tamura, H; Yamashiro, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 287 KB

Intravitreal injection of bevacizumab fo

✍ Wu, P-C; Chen, Y-J 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 319 KB

Intravitreous bevacizumab to treat subfo

✍ Ruiz-Moreno, J M; Gomez-Ulla, F; Montero, J A; Ares, S; Lopez-Lopez, F; Rodrigue 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Myopic choroidal neovascularization trea

✍ Jose M. Ruiz-Moreno; Javier A. Montero; Pedro Amat-Peral 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 131 KB

Intravitreal bevacizumab on myopic choro

✍ Kengo Hayashi; Kyoko Ohno-Matsui; Noriaki Shimada; Muka Moriyama; Wakako Hara; T 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 537 KB

Choroidal neovascularisation secondary t

✍ Jörg Leu; Norbert F. Schrage; Robert F. Degenring 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 175 KB